Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J JOLLY

Showing results (251-260 of 295) with videos related to

Pageof 30
Sort By:
Journal of Virology|January 1, 1996
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transferT W Dubensky, D A Driver, J M Polo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with GliomaWilliam P Accomando, Aliz R Rao, Daniel J Hogan, et al.
Cancer Gene Therapy|May 9, 2018
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancerKazuho Inoko, Kei Hiraoka, Akihito Inagaki, et al.
Cancer Gene Therapy|August 24, 2013
Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma modelT T Huang, J Hlavaty, D Ostertag, et al.
Human Gene Therapy|November 25, 2014
Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma modelTiffany T Huang, Shraddha Parab, Ryan Burnett, et al.
The CRISPR Journal|September 26, 2025
Efficient CRISPR-Cas9-Mediated Genome Editing of the Cane Toad (<i>Rhinella marina</i>)Michael B Clark, Alexander T Funk, Alex Paporakis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2012
Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expressionOmar D Perez, Christopher R Logg, Kei Hiraoka, et al.
Mobile DNA|April 11, 2018
A computational reconstruction of <i>Papio</i> phylogeny using <i>Alu</i> insertion polymorphismsVallmer E Jordan, Jerilyn A Walker, Thomas O Beckstrom, et al.
Neuro-Oncology|April 8, 2017
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunityKei Hiraoka, Akihito Inagaki, Yuki Kato, et al.
Biological Reviews of the Cambridge Philosophical Society|March 23, 2022
Fire as a driver and mediator of predator-prey interactionsTim S Doherty, William L Geary, Chris J Jolly, et al.
Pageof 30

Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
Journal of Virology|January 1, 1996
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transferT W Dubensky, D A Driver, J M Polo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with GliomaWilliam P Accomando, Aliz R Rao, Daniel J Hogan, et al.
Cancer Gene Therapy|May 9, 2018
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancerKazuho Inoko, Kei Hiraoka, Akihito Inagaki, et al.
Cancer Gene Therapy|August 24, 2013
Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma modelT T Huang, J Hlavaty, D Ostertag, et al.
Human Gene Therapy|November 25, 2014
Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma modelTiffany T Huang, Shraddha Parab, Ryan Burnett, et al.
The CRISPR Journal|September 26, 2025
Efficient CRISPR-Cas9-Mediated Genome Editing of the Cane Toad (<i>Rhinella marina</i>)Michael B Clark, Alexander T Funk, Alex Paporakis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2012
Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expressionOmar D Perez, Christopher R Logg, Kei Hiraoka, et al.
Mobile DNA|April 11, 2018
A computational reconstruction of <i>Papio</i> phylogeny using <i>Alu</i> insertion polymorphismsVallmer E Jordan, Jerilyn A Walker, Thomas O Beckstrom, et al.
Neuro-Oncology|April 8, 2017
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunityKei Hiraoka, Akihito Inagaki, Yuki Kato, et al.
Biological Reviews of the Cambridge Philosophical Society|March 23, 2022
Fire as a driver and mediator of predator-prey interactionsTim S Doherty, William L Geary, Chris J Jolly, et al.
Pageof 30